StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Moderna (MRNA) Declines 7% Pre-Open Following Interim Phase 1 Data for mRNA Flu Vaccine and Program Update
December 10, 2021 7:13 AM
Moderna (NASDAQ: MRNA) Declines ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Hot FDA News
Trader Talk
Next Articles
Moderna's (MRNA) COVID-19 Vaccine Manufactured in Korea by Samsung Granted Marketing Authorization from Ministry of Food and Drug Safety of Korea
December 14, 2021 5:46 AM
Moderna (MRNA) Reports Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update
December 10, 2021 7:00 AM
Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update
December 10, 2021 7:00 AM
